Skip to main content
Clinical Trials/NL-OMON42650
NL-OMON42650
Completed
Not Applicable

On the origin of cerebral small vessel disease - On the origin of cerebral small vessel disease

eurologie0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cerebral small vessel disease
Sponsor
eurologie
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
eurologie

Eligibility Criteria

Inclusion Criteria

  • Participants will be recruited from our ongoing RUNDMC study. The current proposal can be seen as an extension of the RUNDMC Study. Eligibility criteria for participation with the RUNDMC study included the presence of cerebral small vessel disease on neuroimaging (made because of symptoms of small vessel disease), age 50\-85 years.
  • For the current extension the following inclusion criteria will be added:;\- Above RUNDMC average progression of cerebral small vessel disease as assessed on sequential MRI scanning in 2006 and 2012\.
  • \- Have risk factors of progression
  • \- Hypertension
  • \- IADL \> 6 (functionally independent)
  • \- Being able to visit the research centre on a monthly basis

Exclusion Criteria

  • \- Atrial fibrillation
  • \- carotid artery stenosis \> 50%
  • \- Dementia
  • \- Mild cognitive impairment
  • \- Parkinsonism
  • \- Diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials